Effects of Rivoglitazone on Metabolic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Truitt, Kenneth E.
Moberly, James
Schwocho, Lee
Mun, Yong
Chou, Hubert S.
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A182 / A182
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF CANAGLIFLOZIN VERSUS GLIMEPIRIDE ON INFLAMMATORY BIOMARKERS AND CHEMOKINES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Van Gaal, Luc
    Garvey, Tim
    Leiter, Lawrence
    Vijapurkar, Ujjwala
    List, James
    Cuddihy, Robert
    Ren, Jimmy
    Davies, Michael
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1672 - 1672
  • [2] Efficacy and Safety of Rivoglitazone as Monotherapy for Type 2 Diabetes Mellitus
    Chou, Hubert S.
    Moberly, James
    Mun, Yong
    Choi, Youngsook
    Merante, Domenico
    Truitt, Kenneth E.
    [J]. DIABETES, 2010, 59 : A183 - A183
  • [3] Rivoglitazone: A New Thiazolidinedione for the Treatment of Type 2 Diabetes Mellitus
    Koffarnus, Robin L.
    Wargo, Kurt A.
    Phillippe, Haley M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2013, 47 (06) : 877 - 885
  • [4] Effects of rosiglitazone alone and in combination with atorvastatin on serum inflammatory biomarkers in patients with type 2 diabetes mellitus
    Chu, C. S.
    Lee, K. T.
    Lee, M. Y.
    Lee, S. T.
    Cheng, K. H.
    Voon, W. C.
    Sheu, S. H.
    Lai, W. T.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 293 - 294
  • [5] The Effects of Prebiotics and Substances with Prebiotic Properties on Metabolic and Inflammatory Biomarkers in Individuals with Type 2 Diabetes Mellitus: A Systematic Review
    Colantonio, Angela G.
    Werner, Sharon L.
    Brown, Melissa
    [J]. JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS, 2020, 120 (04) : 587 - +
  • [6] Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2
    Lerch, M
    Weidmann, P
    Ho, MP
    Gerber, P
    Eckenberger, P
    Kaemmereit, A
    Teuscher, AU
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 33 (04) : 527 - 533
  • [7] Role of inflammatory biomarkers in nephropathy and atherosclerosis in type 2 diabetes mellitus patients with microalbuminuria
    Cirkin, H.
    Bagca, B. Goker
    Kilavuz, A.
    Sarac, F.
    Selvi, N.
    Birkay, C. Avci
    Sagin, H.
    Sagin, F.
    [J]. FEBS OPEN BIO, 2021, 11 : 450 - 451
  • [8] Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2
    Koshelskaya, Olga A.
    Kharitonova, Olga A.
    Kologrivova, Irina, V
    Suslova, Tatiana E.
    Margolis, Natalia Yu
    Tereshenkova, Ekaterina K.
    Rybina, Anastasiia N.
    Karpov, Rostislav S.
    [J]. TERAPEVTICHESKII ARKHIV, 2021, 93 (09): : 1030 - 1036
  • [9] Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus Patients
    Gorety Jacobo-Cejudo, M.
    Valdes-Ramos, Roxana
    Guadarrama-Lopez, Ana L.
    Pardo-Morales, Rosa-Virgen
    Martinez-Carrillo, Beatriz E.
    Harbige, Laurence S.
    [J]. NUTRIENTS, 2017, 9 (06):
  • [10] Association of Inflammatory and Metabolic Biomarkers with Mitral Annular Calcification in Type 2 Diabetes Patients
    Grigorescu, Elena-Daniela
    Lacatusu, Cristina-Mihaela
    Floria, Mariana
    Cazac, Georgiana-Diana
    Onofriescu, Alina
    Ceasovschih, Alexandr
    Cretu, Ioana
    Mihai, Bogdan-Mircea
    Sorodoc, Laurentiu
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (09):
12345